Raymond James lowered the firm’s price target on Colgate-Palmolive (CL) to $105 from $110 and keeps an Outperform rating on the shares. The firm is entering 2025 more cautious on Colgate-Palmolive following a larger than expected sales decline in Q4, but believes the long-term potential remains attractive, the analyst tells investors in a research note. The impact of new tariffs on goods from Mexico and China should be minimal to annualized EPS, helped by accelerating savings from Funding the Growth, the firm says.
Maximize Your Portfolio with Data Driven Insights:
- Leverage the power of TipRanks' Smart Score, a data-driven tool to help you uncover top performing stocks and make informed investment decisions.
- Monitor your stock picks and compare them to top Wall Street Analysts' recommendations with Your Smart Portfolio
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CL:
- Colgate-Palmolive price target lowered to $100 from $105 at Evercore ISI
- Colgate-Palmolive price target lowered to $93 from $95 at Stifel
- Colgate-Palmolive price target lowered to $104 from $111 at Morgan Stanley
- Elon Musk’s X Adds More Companies to Ad-Boycott Lawsuit
- Colgate-Palmolive: Positive Outlook Amid Growth Challenges